Company profile: DiaSys Diagnostics
1.1 - Company Overview
Company description
- Provider of diagnostic system solutions, offering over 90 liquid-stable, ready-to-use reagents for clinical chemistry and immunoturbidimetric diagnostics (routine and special), including Procalcitonin FS, LDH 21 FS, LDL-c direct FS, and Total bile acids 21 FS, as well as automated and semi-automated clinical chemistry analyzers.
Products and services
- Clinical Chemistry Analyzers: DiaSys delivers automated and semi-automated analyzers for clinical chemistry applications, automation-oriented instruments constructed to run clinical chemistry assays with consistent, repeatable operation
- Reagents: DiaSys supplies over 90 liquid-stable, ready-to-use reagents for clinical chemistry and immunoturbidimetric diagnostics, engineered for routine and special diagnostics across diverse testing workflows
- LDL-c direct FS: DiaSys produces a homogenous assay for direct determination of low-density lipoprotein cholesterol in serum and plasma, enabling LDL-c measurement within clinical chemistry workflows
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DiaSys Diagnostics
Cytena
HQ: Germany
Website
- Description: Provider of single-cell printing and isolation technologies for cell research and professional diagnostics, offering the cy-Clone device to separate single cells for biologics development and genetic analysis in cancer and stem cell research, and instruments including UP.SIGHT, C.SIGHT 2.0, B.SIGHT, CELLCYTE X, C.WASH PLUS, and the C.LIVE Caspase-3 Green NucView assay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cytena company profile →
CrestOptics
HQ: Italy
Website
- Description: Provider of advanced fluorescence microscopy systems and modules, including CICERO widefield and spinning disk confocal for inverted/upright setups with wide spectral range and high resolution; X-Light V3 spinning disk confocal enabling dual-camera, high-speed, large FOV imaging; DeepSIM super-resolution module; and VisiView software for integrating and optimizing imaging protocols.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CrestOptics company profile →
myPOLS Biotec
HQ: Germany
Website
- Description: Provider of best-in-class DNA polymerases, master mixes, DNA polymerase-based assays, and reagents in liquid and lyophilized formats for IVD and research use, based in Konstanz, Germany.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full myPOLS Biotec company profile →
Alamar Biosciences
HQ: United States
Website
- Description: Provider of technologies enabling the earliest possible detection and treatment of cancer and other diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alamar Biosciences company profile →
Enza Biotech
HQ: Sweden
Website
- Description: Provider of research and development of renewable surfactants using carbohydrate-based chemistry, operating at the intersection of science and business to support the transition from a fossil-dependent to a biobased society; founded in 2012 and based at Chemical Center in Lund, Southern Sweden.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Enza Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DiaSys Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DiaSys Diagnostics
2.2 - Growth funds investing in similar companies to DiaSys Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DiaSys Diagnostics
4.2 - Public trading comparable groups for DiaSys Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →